Treasury Management at Halifax Bank of Scotland and GlaxoSmithKline. It needs to be at least 2750 words. When the business enterprise approaches a financial institution for obtaining the credit facilities, the enterprise is required to submit some important financial statements (profit and loss account, balance sheet etc.) and any further information relating to its activity. The financial statement of a company is prepared by qualified persons in terms of the relevant statutes. It may arise in anyone’s mind, that, when such is the case, is it not redundancy for another person to analyze the same. The answer to this is, financial statements are generally prepared to cater to the needs of the shareholders and/or the government. The relevant law mandates that the compilation/presentation of a financial statement is primarily focused on the information required by the owner and the statutory body. On the other hand, the treasury management personnel look at the financial statements from an entirely different angle. In order to ensure that, the figures in statements are meaningful, from treasury management’s point of view, he splits and assembles the figures in different combinations and makes an attempt to derive meaningful conclusions from such reassembled set of figures. Besides, the treasury management personnel puts to test, the sustainability of figures like profit, cash accruals and other related financials under different stress conditions. These tests undertaken will throw light on the company about the level of strength, sustainability and capacity to service the funds mobilized. in short described as analysis of the financial statement.
Keeping the above broad parameters in mind an attempt has been made to analyze and interpret the financials of two real companies in a real business setting. The subjects of analysis are GlaxoSmithKline (GSK), a leading pharmaceutical company and Halifax Bank of Scotland (HBOS), a premium bank operating in Europe.
GlaxoSmithKline plc (GSK), is a multi-billion pound British based company that deals with the manufacturing oh pharmaceutical, clinical and health care products. Being the second-largest pharmaceutical company in the world (Wikipedia, 2007), GSK recorded a profit of £7.8 billion in 2006. .